| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ULTRAGENYX PHARMACEUTICAL INC COM | 200,000 | 14,188,000 | 5.04% | ||
| 2 | BIOGEN INC | 45,000 | 14,086,000 | 5.01% | ||
| 3 | SHIRE PLC | 65,000 | 12,601,000 | 4.48% | ||
| 4 | CLOVIS ONCOLOGY INC | 325,000 | 11,716,000 | 4.16% | ||
| 5 | ZIMMER BIOMET HLDGS INC | 85,000 | 11,052,000 | 3.93% | ||
| 6 | ALEXION PHARMACEUTIC | 75,000 | 9,191,000 | 3.27% | ||
| 7 | AMGEN INC | 55,000 | 9,175,000 | 3.26% | ||
| 8 | GW PHARMACEUTICALS PLC | 65,000 | 8,627,000 | 3.07% | Put | |
| 9 | PFIZER INC | 250,000 | 8,468,000 | 3.01% | ||
| 10 | ONCOMED PHARMACEUTICALS INC | 725,000 | 8,287,000 | 2.95% | ||
| 11 | CELGENE CORP | 75,000 | 7,840,000 | 2.79% | ||
| 12 | CELGENE CORP | 75,000 | 7,839,000 | 2.79% | Call | |
| 13 | MEDICINES CO | 200,000 | 7,548,000 | 2.68% | ||
| 14 | GLOBAL BLOOD THERAPEUTICS IN COM | 325,000 | 7,491,000 | 2.66% | ||
| 15 | NUVASIVE INC COM | 100,000 | 6,666,000 | 2.37% | ||
| 16 | AERIE PHARMACEUTICALS INC | 165,000 | 6,227,000 | 2.21% | ||
| 17 | MAZOR ROBOTICS LTD | 200,000 | 5,174,000 | 1.84% | ||
| 18 | ALNYLAM PHARMACEUTICALS INC | 75,000 | 5,083,000 | 1.81% | ||
| 19 | DERMIRA INC | 150,000 | 5,073,000 | 1.80% | ||
| 20 | GILEAD SCIENCES INC | 60,000 | 4,747,000 | 1.69% | ||
| 21 | MERCK & CO INC | 75,000 | 4,681,000 | 1.66% | ||
| 22 | GLAUKOS CORP | 120,000 | 4,529,000 | 1.61% | ||
| 23 | EXELIXIS INC | 350,000 | 4,477,000 | 1.59% | ||
| 24 | HEALTHWAYS INC | 165,000 | 4,366,000 | 1.55% | ||
| 25 | SUPERNUS PHARMACEUTICALS INC COM | 150,000 | 3,710,000 | 1.32% | ||
| 26 | BRISTOL MYERS SQUIBB CO | 65,000 | 3,505,000 | 1.25% | ||
| 27 | MERUS N V | 200,000 | 3,350,000 | 1.19% | ||
| 28 | GW PHARMACEUTICALS PLC | 25,000 | 3,318,000 | 1.18% | Call | |
| 29 | CIGNA CORPORATION | 25,000 | 3,258,000 | 1.16% | Call | |
| 30 | MINERVA NEUROSCIENCES INC COM | 225,000 | 3,176,000 | 1.13% | ||
| 31 | ANTHEM INC | 25,000 | 3,133,000 | 1.11% | ||
| 32 | ALLSCRIPTS HEALTHCARE | 225,000 | 2,963,000 | 1.05% | ||
| 33 | K2M GROUP HLDGS INC COM | 165,000 | 2,934,000 | 1.04% | ||
| 34 | SPECTRANETICS CORP | 110,000 | 2,760,000 | 0.98% | ||
| 35 | GW PHARMACEUTICALS PLC | 20,000 | 2,655,000 | 0.94% | ||
| 36 | PACIRA BIOSCIENCES INC | 75,000 | 2,567,000 | 0.91% | ||
| 37 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 200,000 | 2,480,000 | 0.88% | ||
| 38 | ALDER BIOPHARMACEUTICALS INC | 75,000 | 2,458,000 | 0.87% | ||
| 39 | AERIE PHARMACEUTICALS INC | 65,000 | 2,453,000 | 0.87% | Put | |
| 40 | LHC GROUP INC COM | 65,000 | 2,397,000 | 0.85% | ||
| 41 | IMPAX LABORATORIES INC | 100,000 | 2,370,000 | 0.84% | ||
| 42 | RETROPHIN INC COM | 100,000 | 2,238,000 | 0.80% | ||
| 43 | BIOSCRIP INC | 750,000 | 2,168,000 | 0.77% | ||
| 44 | PHARMERICA CORP | 75,000 | 2,105,000 | 0.75% | ||
| 45 | ACCELERATE DIAGNOSTICS INC | 75,000 | 2,045,000 | 0.73% | ||
| 46 | IONIS PHARMACEUTICALS INC | 50,000 | 1,832,000 | 0.65% | ||
| 47 | ACADIA HEALTHCARE COMPANY IN | 35,000 | 1,734,000 | 0.62% | ||
| 48 | KITE PHARMA INCORPORATED | 30,000 | 1,676,000 | 0.60% | ||
| 49 | OPHTHOTECH CORP COM | 35,000 | 1,615,000 | 0.57% | ||
| 50 | SAREPTA THERAPEUTICS INC | 25,000 | 1,535,000 | 0.55% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-16-000024, filed 2016.11.17). Although 0001597549-16-000024 is marked by the manager as a New Holdings filing, our automated system processes it as a Restatement filing.
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
